Cryptocurrencies
Bank of America sees major upside in this biotech stock
Alvotech has spent years building a biosimilar platform that Wall Street has struggled to value through regulatory delays, manufacturing investment, and uneven commercial results. Bank of America now thinks the investment case is entering a Read more…